MarketPeel
Insider Trading Intelligence
RR

Ramiro Ribeiro

EYPT
CHIEF MEDICAL OFFICER · EYEPOINT, INC. · CIK 0002013623
FILING MIX · LIFETIME42%/58%
BUYS
11
SELLS
15
TOTAL VALUE
$1.40M
COMPANIES
1
ACTIVE SINCE
Jan 2025
HOLDINGS NOW
2,438
AVG SELL PX
$16.61
TRADE KIND
SHOWING 26 / 26
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 14 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Ramiro Ribeiro, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+60.00%+0.15%-0.47%+0.62%-8.30%
14d5+60.00%+0.74%-1.00%+1.73%-9.37%
30d5+80.00%-6.93%-0.49%-6.44%-15.05%
60d5+60.00%-2.44%+2.90%-5.34%-7.41%
90d5(1 pending)+75.00%-9.74%+2.04%-6.84%-19.10%
180d5(3 pending)+50.00%-2.13%+8.27%-10.40%-10.40%
1y5(5 pending)
2y5(5 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EYPT · 2,438 shares · as of Jun 30, 2026
042,85085,700128,550171,4002026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 15 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EYPT
EYEPOINT, INC.
SALE
Chief Medical Officer
2,43778,001Jun 30, 2026Jul 2, 2026View →
EYPT
EYEPOINT, INC.
SALE10b5-1
10b5-1 plan
2,437$15.00$36.6K2,438Jun 30, 2026Jul 2, 2026View →
EYPT
EYEPOINT, INC.
SALE10b5-1
10b5-1 plan
2,438$15.02$36.6K0Jun 30, 2026Jul 2, 2026View →
EYPT
EYEPOINT, INC.
SALE
Chief Medical Officer
2,43875,563Jun 30, 2026Jul 2, 2026View →
EYPT
EYEPOINT, INC.
PURCHASE
Chief Medical Officer
2,438$8.26$20.1K4,875Jun 30, 2026Jul 2, 2026View →
EYPT
EYEPOINT, INC.
PURCHASE
Chief Medical Officer
2,437$8.26$20.1K2,437Jun 30, 2026Jul 2, 2026View →
EYPT
EYEPOINT, INC.
SALE
Chief Medical Officer
2,43780,438Apr 17, 2026Apr 20, 2026View →
EYPT
EYEPOINT, INC.
SALE10b5-1
10b5-1 plan
2,437$15.00$36.6K0Apr 17, 2026Apr 20, 2026View →
EYPT
EYEPOINT, INC.
PURCHASE
Chief Medical Officer
2,437$8.26$20.1K2,437Apr 17, 2026Apr 20, 2026View →
EYPT
EYEPOINT, INC.
SALE10b5-1
10b5-1 plan
2,438$17.87$43.6K0Mar 4, 2026Mar 5, 2026View →
EYPT
EYEPOINT, INC.
PURCHASE
Chief Medical Officer
2,438$8.26$20.1K2,438Mar 4, 2026Mar 5, 2026View →
EYPT
EYEPOINT, INC.
SALE
Chief Medical Officer
2,43882,875Mar 4, 2026Mar 5, 2026View →
EYPT
EYEPOINT, INC.
SALE
Chief Medical Officer
2,43785,313Feb 17, 2026Feb 18, 2026View →
EYPT
EYEPOINT, INC.
SALE10b5-1
10b5-1 plan
2,437$15.00$36.6K0Feb 17, 2026Feb 18, 2026View →
EYPT
EYEPOINT, INC.
PURCHASE
Chief Medical Officer
2,437$8.26$20.1K2,437Feb 17, 2026Feb 18, 2026View →
EYPT
EYEPOINT, INC.
SALE
Chief Medical Officer
29,25087,750Jan 5, 2026Jan 7, 2026View →
EYPT
EYEPOINT, INC.
SALE10b5-1
10b5-1 plan
42,544$17.10$727.3K0Jan 5, 2026Jan 7, 2026View →
EYPT
EYEPOINT, INC.
PURCHASE
Chief Medical Officer
29,250$8.26$241.6K42,544Jan 5, 2026Jan 7, 2026View →
EYPT
EYEPOINT, INC.
PURCHASE
Chief Medical Officer
19,66719,667Jan 3, 2026Jan 6, 2026View →
EYPT
EYEPOINT, INC.
SALE
Chief Medical Officer
6,373$17.48$111.4K13,294Jan 3, 2026Jan 6, 2026View →
EYPT
EYEPOINT, INC.
SALE
Chief Medical Officer
19,66739,333Jan 3, 2026Jan 6, 2026View →
EYPT
EYEPOINT, INC.
PURCHASEGRANT
Stock grant
85,70085,700Jan 2, 2026Jan 6, 2026View →
EYPT
EYEPOINT, INC.
PURCHASEGRANT
Stock grant
171,400171,400Jan 2, 2026Jan 6, 2026View →
EYPT
EYEPOINT, INC.
SALE10b5-1
10b5-1 plan
2,722$11.61$31.6K0Nov 11, 2025Nov 12, 2025View →
EYPT
EYEPOINT, INC.
PURCHASEGRANT
Stock grant
117,000117,000Jan 3, 2025Jan 7, 2025View →
EYPT
EYEPOINT, INC.
PURCHASEGRANT
Stock grant
59,00059,000Jan 3, 2025Jan 7, 2025View →
Other insiders · EYPT
Loading peer insiders…
About this filer
CIK 0002013623
ROLE
Chief Medical Officer
PRIMARY
EYPT
COMPANIES
1
ACTIVE SINCE
Jan 2025
MARKETPEEL · /INSIDER/0002013623DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback